Want to track 4506 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sumitomo Pharma Co., Ltd. (4506) Statistics
Valuation metrics
Market Cap 1.08T
Enterprise value 664.95B
Trailing P/E (ttm) 4.63
Forward P/E 128.66
PEG ratio 0.01
Price/Sales (ttm) 1.22
Price/Book (mrq) 1.38
Enterprise Value/Revenue 1.4
Enterprise Value/EBITDA 5.04
Overview
Shares outstanding 397.29M
Float 183.3M
Shares short -
% Held by insiders 0.55%
% Held by institutions 0.18%
Average volume (10 days) 4.38M
Average volume (90 days) 4.84M
Price summary
52-Week low 1,188
52-Week high 3,288
Beta 0.6
50-Day moving average 1,375.17
200-Day moving average 1,811.07
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 0.24%
Operating margin 0.1%
Operational effectiveness
Return on assets 0.13%
Return on equity 0.36%
Income Statement
Revenue (ttm) 453.39B
Revenue per share (ttm) 1,089.9
Quarterly revenue growth (yoy) 0.07%
Gross profit (ttm) 268.59B
EBITDA 56.67B
Net income to common (ttm) 110.09B
Diluted EPS (ttm) 258.61
Quarterly earnings growth (yoy) -0.83%
Balance Sheet
Total cash (mrq) 57.32B
Total cash per share (mrq) 175.93
Total debt (mrq) 258.95B
Total Debt/Equity (mrq) 0.39
Current ratio (mrq) 1.21%
Book value per share (mrq) 937.86
Cash Flow
Cash flow statement 53.28B
Levered free cash flow (LFCF) 40.3B
